K. Altundag Et Al. , "Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer," UROLOGY , vol.65, no.1, pp.211-212, 2005
Altundag, K. Et Al. 2005. Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer. UROLOGY , vol.65, no.1 , 211-212.
Altundag, K., Altundag, O., Morandi, P., & Gunduz, M., (2005). Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer. UROLOGY , vol.65, no.1, 211-212.
Altundag, K Et Al. "Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer," UROLOGY , vol.65, no.1, 211-212, 2005
Altundag, K Et Al. "Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer." UROLOGY , vol.65, no.1, pp.211-212, 2005
Altundag, K. Et Al. (2005) . "Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer." UROLOGY , vol.65, no.1, pp.211-212.
@article{article, author={K Altundag Et Al. }, title={Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer}, journal={UROLOGY}, year=2005, pages={211-212} }